Colistin Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Formulation [Injectables (IV or IM), Oral, Topical Formulations, and Inhalation Solutions], Indication [Human Health (Bloodstream Infections (BSI) and Sepsis Lower, Respiratory Tract Infections (LRTI), Urinary Tract Infections (UTIs), Central Nervous System Infections, Skin Infections, Cystic Fibrosis, Tracheobronchitis or VAP, Gastrointestinal Infections, and Bowel Decontamination) and Animal Health], Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Channel, and Other Distribution Channels), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
The Colistin market size is expected to grow from US$ 337.00 million in 2025 to US$ 510.94 million by 2034; it is projected to register a CAGR of 4.8% during 2026–2034. The increased multidrug-resistant Gram-negative infections in human healthcare, sustained veterinary demand in livestock and poultry farming are noteworthy factors contributing to the expansion of the colistin market. Additionally, the advancements in novel formulations and delivery systems as well as a rise in combination and synergistic therapies are projected to bring new market drifts in the near future.
The advancement in novel formulations and delivery systems includes the development of liposomal colistin, which encapsulates the drug to reduce nephrotoxicity and improve targeted delivery, particularly for systemic infections. For instance, liposomal formulations are being explored to broaden treatment options beyond traditional injectables, with inhalable and topical preparations gaining traction for respiratory and localized infections. A large-scale clinical trial launched in 2022 evaluated novel colistin formulations in combination therapies, demonstrating improved outcomes in severe cases. The high-purity colistin sulfate segment holds a major share, driven by therapeutic and research applications. In chronic lung infections, nebulized and topical colistin delivery experienced an increase in global clinical trials in 2023, focusing on conditions such as cystic fibrosis and ventilator-associated pneumonia. Advancements in nanotechnology are focused on enhancing colistin's activity, reducing the likelihood of resistance through improved drug penetration. These innovations are expected to sustain demand in niche applications where alternatives are limited, particularly in high-burden regions such as Asia Pacific, which anticipates a major share owing to expanding healthcare infrastructure. Photodynamic therapy (PDT) as an adjunctive method is also being integrated to boost colistin's effectiveness against resistant strains. Overall, innovations in novel formulations and delivery systems aimed at minimizing toxicity, improving bioavailability, and enhancing efficacy against multidrug-resistant infections are expected to be the key trends in the coming years.
Distribution Channel -Based Insights
Based on distribution channel, the colistin market is segmented into hospital pharmacy, retail pharmacy, online channel, and other distribution channel. The hospital pharmacy segment held the largest market share in 2025. Hospital pharmacies serve as the primary distribution channel for colistin in human healthcare, particularly for treating severe multidrug-resistant Gram-negative infections in intensive care settings, where the drug is administered intravenously or via inhalation for conditions like ventilator-associated pneumonia and sepsis. For example, colistin methanesulfonate is commonly stocked in hospital formularies for last-resort use against pathogens such as Acinetobacter baumannii and Pseudomonas aeruginosa, with dosing protocols adjusted for renal function to mitigate nephrotoxicity. In 2023, hospital pharmacies facilitated treatments for over 3.2 million ICU-related infections requiring polymyxin-class antibiotics, with countries like Brazil, Indonesia, and Russia reporting over 37% of severe cases resistant to carbapenems, driving demand. A study indicated that hospital channels account for approximately 60% of colistin distribution in human medicine, supported by direct procurement from manufacturers like Xellia Pharmaceuticals and Fresenius Kabi. Trends show increasing adoption of combination therapies in hospitals, enhancing efficacy while stewardship programs monitor usage to curb resistance. In Europe, the European Medicines Agency regulates hospital supplies, ensuring high-purity formulations. Key players such as Hikma Pharmaceuticals and Teva Pharmaceutical Industries supply through contractual collaborations, emphasizing supply chain resilience amid regulatory frameworks. This channel's dominance stems from colistin's role in acute care, though toxicity concerns limit broader outpatient shifts.
The World Health Organization, Centers for Disease Control and Prevention (CDC), Pan-Canadian Action Plan on Antimicrobial Resistance, European Centre for Disease Prevention and Control (ECDC), UK Health Security Agency (UKHSA), Agency for Health and Food Safety, the National Public Health Organization, Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report, the Australia and New Zealand Group on Antimicrobial Resistance (AGAR), the Ministry of Health, and Labour and Welfare (MHLW) are among the primary and secondary sources referred to while preparing the colistin market report.
Reason to buy
The advancement in novel formulations and delivery systems includes the development of liposomal colistin, which encapsulates the drug to reduce nephrotoxicity and improve targeted delivery, particularly for systemic infections. For instance, liposomal formulations are being explored to broaden treatment options beyond traditional injectables, with inhalable and topical preparations gaining traction for respiratory and localized infections. A large-scale clinical trial launched in 2022 evaluated novel colistin formulations in combination therapies, demonstrating improved outcomes in severe cases. The high-purity colistin sulfate segment holds a major share, driven by therapeutic and research applications. In chronic lung infections, nebulized and topical colistin delivery experienced an increase in global clinical trials in 2023, focusing on conditions such as cystic fibrosis and ventilator-associated pneumonia. Advancements in nanotechnology are focused on enhancing colistin's activity, reducing the likelihood of resistance through improved drug penetration. These innovations are expected to sustain demand in niche applications where alternatives are limited, particularly in high-burden regions such as Asia Pacific, which anticipates a major share owing to expanding healthcare infrastructure. Photodynamic therapy (PDT) as an adjunctive method is also being integrated to boost colistin's effectiveness against resistant strains. Overall, innovations in novel formulations and delivery systems aimed at minimizing toxicity, improving bioavailability, and enhancing efficacy against multidrug-resistant infections are expected to be the key trends in the coming years.
Distribution Channel -Based Insights
Based on distribution channel, the colistin market is segmented into hospital pharmacy, retail pharmacy, online channel, and other distribution channel. The hospital pharmacy segment held the largest market share in 2025. Hospital pharmacies serve as the primary distribution channel for colistin in human healthcare, particularly for treating severe multidrug-resistant Gram-negative infections in intensive care settings, where the drug is administered intravenously or via inhalation for conditions like ventilator-associated pneumonia and sepsis. For example, colistin methanesulfonate is commonly stocked in hospital formularies for last-resort use against pathogens such as Acinetobacter baumannii and Pseudomonas aeruginosa, with dosing protocols adjusted for renal function to mitigate nephrotoxicity. In 2023, hospital pharmacies facilitated treatments for over 3.2 million ICU-related infections requiring polymyxin-class antibiotics, with countries like Brazil, Indonesia, and Russia reporting over 37% of severe cases resistant to carbapenems, driving demand. A study indicated that hospital channels account for approximately 60% of colistin distribution in human medicine, supported by direct procurement from manufacturers like Xellia Pharmaceuticals and Fresenius Kabi. Trends show increasing adoption of combination therapies in hospitals, enhancing efficacy while stewardship programs monitor usage to curb resistance. In Europe, the European Medicines Agency regulates hospital supplies, ensuring high-purity formulations. Key players such as Hikma Pharmaceuticals and Teva Pharmaceutical Industries supply through contractual collaborations, emphasizing supply chain resilience amid regulatory frameworks. This channel's dominance stems from colistin's role in acute care, though toxicity concerns limit broader outpatient shifts.
The World Health Organization, Centers for Disease Control and Prevention (CDC), Pan-Canadian Action Plan on Antimicrobial Resistance, European Centre for Disease Prevention and Control (ECDC), UK Health Security Agency (UKHSA), Agency for Health and Food Safety, the National Public Health Organization, Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report, the Australia and New Zealand Group on Antimicrobial Resistance (AGAR), the Ministry of Health, and Labour and Welfare (MHLW) are among the primary and secondary sources referred to while preparing the colistin market report.
Reason to buy
- Saves and reduces time required for identifying the market growth, size, leading players, and segments in the global Colistin market.
- Highlights key business priorities to assist companies in realigning their business strategies
- Emphasizes key findings and recommendations that uncover emerging industry trends in the global Colistin market, enabling stakeholders across the value chain to craft effective long-term strategies
- Develop/modify business expansion plans by analyzing substantial growth prospects in mature and emerging markets
- Scrutinizes in-depth global Colistin market trends, along with factors driving the market, as well as those hindering it
- Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
1. EXECUTIVE SUMMARY
1.1 Analyst Market Outlook
1.2 Market Attractiveness
2. COLISTIN MARKET LANDSCAPE
2.1 Overview
2.2 Value Chain Analysis
2.2.1 Raw Material Suppliers / Components
2.2.2 Manufacturers/ Process / Technology
2.2.3 Distribution Landscape
2.2.4 End User
2.2.5 Level of Integration
2.3 Supply Chain Analysis
2.3.1 List of Manufacturers/Suppliers
2.3.2 List of Potential Customers (Upto 50)
2.4 Porter`s Five Force Analysis
2.4.1 Bargaining Power of Suppliers: Moderate
2.4.2 Bargaining Power of Buyers: High
2.4.3 Threat of New Entrants: Moderate
2.4.4 Threat of Substitutes: High
2.4.5 Competitive Rivalry: High
2.5 PEST Analysis
2.6 Sustainability and ESG Trends
2.6.1 Sustainability Trends
2.6.2 Environmental Trends
2.6.3 Social Trends
2.6.4 Governance Trends
2.7 Regulatory Framework
2.8 Market Entry Barriers
2.8.1 Regulatory Aspect
2.8.2 Competitive Aspect
2.8.3 Reimbursement-Related Aspect
2.9 CMS Vs Colistin Base Sulphate – Manufacturing & Commercial Assessment
2.10 Global Tender Analysis
2.11 Prevalence of Key 3 Diseases, By Region, 2024
2.12 Pricing Analysis, ASPs of Key Products
2.13 Global Colistin API Market Volume (Tonnes), 2025
2.14 Pipeline Analysis of Next-Generation Polymyxins
3. COMPETITIVE LANDSCAPE
3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis (%), 2025
3.3 Market Concentration
4. COLISTIN MARKET – KEY INDUSTRY DYNAMICS
4.1 Market Drivers
4.1.1 Increased Multidrug-Resistant Gram-Negative Infections in Human Healthcare:
4.1.2 Sustained Veterinary Demand in Livestock and Poultry Farming
4.1.3 Regulatory Shifts and Policies Addressing Antimicrobial Resistance
4.2 Market Restraints
4.2.1 Limiting Clinical Adoption
4.2.2 Increased Prevalence of Colistin Resistance
4.2.3 Stringent Regulatory Policies and Bans
4.3 Market Opportunities
4.3.1 Advancements in Inhaled Colistin Formulations for Respiratory Infections
4.3.2 Expansion of Combination Therapies for Multidrug-Resistant Infections
4.3.3 Regional Market Expansion in Asia Pacific Amid Rising Antimicrobial Resistance
4.4 Future Trends
4.4.1 Advancements in Novel Formulations and Delivery Systems
4.4.2 Rise in Combination and Synergistic Therapies
4.4.3 Enhanced Antimicrobial Stewardship and Regulatory Frameworks
4.5 Impact of Drivers and Restraints
5. COLISTIN MARKET – GLOBAL MARKET ANALYSIS
5.1 Colistin Market Revenue (US$ Million), 2021–2034
5.2 Colistin Market Forecast and Analysis
6. COLISTIN MARKET REVENUE ANALYSIS – FORMULATION
6.1 Colistin Market Forecasts and Analysis by Formulation
6.1.1 Oral
6.1.1.1 Overview
6.1.1.2 Oral: Colistin Market – Revenue, 2021–2034 (US$ Million)
6.1.2 Injectables (IV or IM)
6.1.2.1 Overview
6.1.2.2 Injectables (IV or IM): Colistin Market – Revenue, 2021–2034 (US$ Million)
6.1.3 Topical Formulations
6.1.3.1 Overview
6.1.3.2 Topical Formulations: Colistin Market – Revenue, 2021–2034 (US$ Million)
6.1.4 Inhalation Solutions
6.1.4.1 Overview
6.1.4.2 Inhalation Solutions: Colistin Market – Revenue, 2021–2034 (US$ Million)
7. COLISTIN MARKET REVENUE ANALYSIS – INDICATION
7.1 Colistin Market Forecasts and Analysis by Indication
7.1.1 Animal Health
7.1.1.1 Overview
7.1.1.2 Animal Health Health: Colistin Market – Revenue, 2021–2034 (US$ Million)
7.1.2 Human Health
7.1.2.1 Overview
7.1.2.2 Human Health: Colistin Market – Revenue, 2021–2034 (US$ Million)
8. COLISTIN MARKET REVENUE ANALYSIS – DISTRIBUTION CHANNEL
8.1 Colistin Market Forecasts and Analysis by Distribution Channel
8.1.1 Hospital Pharmacy
8.1.1.1 Overview
8.1.1.2 Hospital Pharmacy: Colistin Market – Revenue, 2021–2034 (US$ Million)
8.1.2 Retail Pharmacy
8.1.2.1 Overview
8.1.2.2 Retail Pharmacy: Colistin Market – Revenue, 2021–2034 (US$ Million)
8.1.3 Online Channel
8.1.3.1 Overview
8.1.3.2 Online Channel: Colistin Market – Revenue, 2021–2034 (US$ Million)
8.1.4 Other Distribution Channel
8.1.4.1 Overview
8.1.4.2 Other Distribution Channel: Colistin Market – Revenue, 2021–2034 (US$ Million)
9. COLISTIN MARKET – GEOGRAPHICAL ANALYSIS
9.1 North America
9.1.1 North America Colistin Market Overview
9.1.2 North America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.3 North America: Colistin Market – By Segmentation
9.1.3.1 Formulation
9.1.3.2 Indication
9.1.3.2.1 Human Health
9.1.3.3 Distribution Channel
9.1.4 North America: Colistin Market Breakdown by Countries
9.1.4.1 United States Market
9.1.4.1.1 United States: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.4.1.2 United States: Colistin Market – By Segmentation
9.1.4.1.2.1 Formulation
9.1.4.1.2.2 Indication
9.1.4.1.2.2.1 Human Health
9.1.4.1.2.3 Distribution Channel
9.1.4.2 Canada Market
9.1.4.2.1 Canada: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.4.2.2 Canada: Colistin Market – By Segmentation
9.1.4.2.2.1 Formulation
9.1.4.2.2.2 Indication
9.1.4.2.2.2.1 Human Health
9.1.4.2.2.3 Distribution Channel
9.1.4.3 Mexico Market
9.1.4.3.1 Mexico: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.4.3.2 Mexico: Colistin Market – By Segmentation
9.1.4.3.2.1 Formulation
9.1.4.3.2.2 Indication
9.1.4.3.2.2.1 Human Health
9.1.4.3.2.3 Distribution Channel
9.2 Europe
9.2.1 Europe Colistin Market Overview
9.2.2 Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.3 Europe: Colistin Market – By Segmentation
9.2.3.1 Formulation
9.2.3.2 Indication
9.2.3.2.1 Human Health
9.2.3.3 Distribution Channel
9.2.4 Europe: Colistin Market Breakdown by Countries
9.2.4.1 Germany Market
9.2.4.1.1 Germany: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.1.2 Germany: Colistin Market – By Segmentation
9.2.4.1.2.1 Formulation
9.2.4.1.2.2 Indication
9.2.4.1.2.2.1 Human Health
9.2.4.1.2.3 Distribution Channel
9.2.4.2 United Kingdom Market
9.2.4.2.1 United Kingdom: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.2.2 United Kingdom: Colistin Market – By Segmentation
9.2.4.2.2.1 Formulation
9.2.4.2.2.2 Indication
9.2.4.2.2.2.1 Human Health
9.2.4.2.2.3 Distribution Channel
9.2.4.3 France Market
9.2.4.3.1 France: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.3.2 France: Colistin Market – By Segmentation
9.2.4.3.2.1 Formulation
9.2.4.3.2.2 Indication
9.2.4.3.2.2.1 Human Health
9.2.4.3.2.3 Distribution Channel
9.2.4.4 Italy Market
9.2.4.4.1 Italy: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.4.2 Italy: Colistin Market – By Segmentation
9.2.4.4.2.1 Formulation
9.2.4.4.2.2 Indication
9.2.4.4.2.2.1 Human Health
9.2.4.4.2.3 Distribution Channel
9.2.4.5 Spain Market
9.2.4.5.1 Spain: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.5.2 Spain: Colistin Market – By Segmentation
9.2.4.5.2.1 Formulation
9.2.4.5.2.2 Indication
9.2.4.5.2.2.1 Human Health
9.2.4.5.2.3 Distribution Channel
9.2.4.6 Poland Market
9.2.4.6.1 Poland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.6.2 Poland: Colistin Market – By Segmentation
9.2.4.6.2.1 Formulation
9.2.4.6.2.2 Indication
9.2.4.6.2.2.1 Human Health
9.2.4.6.2.3 Distribution Channel
9.2.4.7 Romania Market
9.2.4.7.1 Romania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.7.2 Romania: Colistin Market – By Segmentation
9.2.4.7.2.1 Formulation
9.2.4.7.2.2 Indication
9.2.4.7.2.2.1 Human Health
9.2.4.7.2.3 Distribution Channel
9.2.4.8 Serbia Market
9.2.4.8.1 Serbia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.8.2 Serbia: Colistin Market – By Segmentation
9.2.4.8.2.1 Formulation
9.2.4.8.2.2 Indication
9.2.4.8.2.2.1 Human Health
9.2.4.8.2.3 Distribution Channel
9.2.4.9 Bulgaria Market
9.2.4.9.1 Bulgaria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.9.2 Bulgaria: Colistin Market – By Segmentation
9.2.4.9.2.1 Formulation
9.2.4.9.2.2 Indication
9.2.4.9.2.2.1 Human Health
9.2.4.9.2.3 Distribution Channel
9.2.4.10 Czech Republic Market
9.2.4.10.1 Czech Republic: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.10.2 Czech Republic: Colistin Market – By Segmentation
9.2.4.10.2.1 Formulation
9.2.4.10.2.2 Indication
9.2.4.10.2.2.1 Human Health
9.2.4.10.2.3 Distribution Channel
9.2.4.11 Belgium Market
9.2.4.11.1 Belgium: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.11.2 Belgium: Colistin Market – By Segmentation
9.2.4.11.2.1 Formulation
9.2.4.11.2.2 Indication
9.2.4.11.2.2.1.1 Human Health
9.2.4.11.2.3 Distribution Channel
9.2.4.12 Slovakia Market
9.2.4.12.1 Slovakia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.12.2 Slovakia: Colistin Market – By Segmentation
9.2.4.12.2.1 Formulation
9.2.4.12.2.2 Indication
9.2.4.12.2.2.1 Human Health
9.2.4.12.2.3 Distribution Channel
9.2.4.13 Ireland Market
9.2.4.13.1 Ireland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.13.2 Ireland: Colistin Market – By Segmentation
9.2.4.13.2.1 Formulation
9.2.4.13.2.2 Indication
9.2.4.13.2.2.1 Human Health
9.2.4.13.2.3 Distribution Channel
9.2.4.14 Hungary Market
9.2.4.14.1 Hungary: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.14.2 Hungary: Colistin Market – By Segmentation
9.2.4.14.2.1 Formulation
9.2.4.14.2.2 Indication
9.2.4.14.2.2.1 Human Health
9.2.4.14.2.3 Distribution Channel
9.2.4.15 Portugal Market
9.2.4.15.1 Portugal: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.15.2 Portugal: Colistin Market – By Segmentation
9.2.4.15.2.1 Formulation
9.2.4.15.2.2 Indication
9.2.4.15.2.2.1 Human Health
9.2.4.15.2.3 Distribution Channel
9.2.4.16 Lithuania Market
9.2.4.16.1 Lithuania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.16.2 Lithuania: Colistin Market – By Segmentation
9.2.4.16.2.1 Formulation
9.2.4.16.2.2 Indication
9.2.4.16.2.2.1 Human Health
9.2.4.16.2.3 Distribution Channel
9.2.4.17 Austria Market
9.2.4.17.1 Austria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.17.2 Austria: Colistin Market – By Segmentation
9.2.4.17.2.1 Formulation
9.2.4.17.2.2 Indication
9.2.4.17.2.2.1 Human Health
9.2.4.17.2.3 Distribution Channel
9.2.4.18 Bosnia Market
9.2.4.18.1 Bosnia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.18.2 Bosnia: Colistin Market – By Segmentation
9.2.4.18.2.1 Formulation
9.2.4.18.2.2 Indication
9.2.4.18.2.2.1 Human Health
9.2.4.18.2.3 Distribution Channel
9.2.4.19 Latvia Market
9.2.4.19.1 Latvia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.19.2 Latvia: Colistin Market – By Segmentation
9.2.4.19.2.1 Formulation
9.2.4.19.2.2 Indication
9.2.4.19.2.2.1 Human Health
9.2.4.19.2.3 Distribution Channel
9.2.4.20 Netherlands Market
9.2.4.20.1 Netherlands: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.20.2 Netherlands: Colistin Market – By Segmentation
9.2.4.20.2.1 Formulation
9.2.4.20.2.2 Indication
9.2.4.20.2.2.1 Human Health
9.2.4.20.2.3 Distribution Channel
9.2.4.21 Greece Market
9.2.4.21.1 Greece: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.21.2 Greece: Colistin Market – By Segmentation
9.2.4.21.2.1 Formulation
9.2.4.21.2.2 Indication
9.2.4.21.2.2.1 Human Health
9.2.4.21.2.3 Distribution Channel
9.2.4.22 Rest of Europe Market
9.2.4.22.1 Rest of Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.22.2 Rest of Europe: Colistin Market – By Segmentation
9.2.4.22.2.1 Formulation
9.2.4.22.2.2 Indication
9.2.4.22.2.2.1 Human Health
9.2.4.22.2.3 Distribution Channel
9.3 Asia Pacific
9.3.1 Asia Pacific Colistin Market Overview
9.3.2 Asia Pacific: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.3 Asia Pacific: Colistin Market – By Segmentation
9.3.3.1 Formulation
9.3.3.2 Indication
9.3.3.2.1 Human Health
9.3.3.3 Distribution Channel
9.3.4 Asia Pacific: Colistin Market Breakdown by Countries
9.3.4.1 Australia and New Zealand Market
9.3.4.1.1 Australia and New Zealand: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.1.2 Australia and New Zealand: Colistin Market – By Segmentation
9.3.4.1.2.1 Formulation
9.3.4.1.2.2 Indication
9.3.4.1.2.2.1 Human Health
9.3.4.1.2.3 Distribution Channel
9.3.4.2 Japan Market
9.3.4.2.1 Japan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.2.2 Japan: Colistin Market – By Segmentation
9.3.4.2.2.1 Formulation
9.3.4.2.2.2 Indication
9.3.4.2.2.2.1 Human Health
9.3.4.2.2.3 Distribution Channel
9.3.4.3 Kazakhstan Market
9.3.4.3.1 Kazakhstan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.3.2 Kazakhstan: Colistin Market – By Segmentation
9.3.4.3.2.1 Formulation
9.3.4.3.2.2 Indication
9.3.4.3.2.2.1 Human Health
9.3.4.3.2.3 Distribution Channel
9.3.4.4 Rest of APAC Market
9.3.4.4.1 Rest of APAC: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.4.2 Rest of APAC: Colistin Market – By Segmentation
9.3.4.4.2.1 Formulation
9.3.4.4.2.2 Indication
9.3.4.4.2.2.1 Human Health
9.3.4.4.2.3 Distribution Channel
9.4 Middle East and Africa
9.4.1 Middle East and Africa Colistin Market Overview
9.4.2 Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.4.3 Middle East and Africa: Colistin Market – By Segmentation
9.4.3.1 Formulation
9.4.3.2 Indication
9.4.3.2.1 Human Health
9.4.3.3 Distribution Channel
9.4.4 Middle East and Africa: Colistin Market Breakdown by Countries
9.4.4.1 Saudi Arabia Market
9.4.4.1.1 Saudi Arabia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.4.4.1.2 Saudi Arabia: Colistin Market – By Segmentation
9.4.4.1.2.1 Formulation
9.4.4.1.2.2 Indication
9.4.4.1.2.2.1 Human Health
9.4.4.1.2.3 Distribution Channel
9.4.4.2 Rest of Middle East and Africa Market
9.4.4.2.1 Rest of Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.4.4.2.2 Rest of Middle East and Africa: Colistin Market – By Segmentation
9.4.4.2.2.1 Formulation
9.4.4.2.2.2 Indication
9.4.4.2.2.2.1 Human Health
9.4.4.2.2.3 Distribution Channel
9.5 South and Central America
9.5.1 South and Central America Colistin Market Overview
9.5.2 South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.5.3 South and Central America: Colistin Market – By Segmentation
9.5.3.1 Formulation
9.5.3.2 Indication
9.5.3.2.1 Human Health
9.5.3.3 Distribution Channel
9.5.4 South and Central America: Colistin Market Breakdown by Countries
9.5.4.1 Brazil Market
9.5.4.1.1 Brazil: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.5.4.1.2 Brazil: Colistin Market – By Segmentation
9.5.4.1.2.1 Formulation
9.5.4.1.2.2 Indication
9.5.4.1.2.2.1 Human Health
9.5.4.1.2.3 Distribution Channel
9.5.4.2 Rest of South and Central America Market
9.5.4.2.1 Rest of South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.5.4.2.2 Rest of South and Central America: Colistin Market – By Segmentation
9.5.4.2.2.1 Formulation
9.5.4.2.2.2 Indication
9.5.4.2.2.2.1 Human Health
9.5.4.2.2.3 Distribution Channel
10. COLISTIN MARKET INDUSTRY LANDSCAPE
11. COLISTIN MARKET – KEY COMPANY PROFILES
11.1 Hebei Shengxue Dacheng Pharmaceutical Co., Ltd
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Norma Hellas S.A
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Apeloa Pharmaceutical Co., Ltd.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Livzon Pharmaceutical Group Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Shandong LuKang Pharmaceutical Co., Ltd
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Xellia Pharmaceuticals ApS
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Zhejiang Shenghua Biok Chemical Company Limited
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Fujian lifecome biochemistry Limited
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Tecoland Corporation
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 TZF Polfa S.A.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. APPENDIX
12.1 Glossary
12.2 Research Methodology and Approach
12.2.1 Secondary Research
12.2.2 Primary Research
12.2.3 Market Estimation Approach
12.2.3.1 Supply Side Analysis
12.2.3.2 Demand Side Analysis
12.2.4 Research Assumptions and Limitations
12.2.5 Currency Conversion
12.3 About The Insight Partners
12.4 Market Intelligence Cloud
1.1 Analyst Market Outlook
1.2 Market Attractiveness
2. COLISTIN MARKET LANDSCAPE
2.1 Overview
2.2 Value Chain Analysis
2.2.1 Raw Material Suppliers / Components
2.2.2 Manufacturers/ Process / Technology
2.2.3 Distribution Landscape
2.2.4 End User
2.2.5 Level of Integration
2.3 Supply Chain Analysis
2.3.1 List of Manufacturers/Suppliers
2.3.2 List of Potential Customers (Upto 50)
2.4 Porter`s Five Force Analysis
2.4.1 Bargaining Power of Suppliers: Moderate
2.4.2 Bargaining Power of Buyers: High
2.4.3 Threat of New Entrants: Moderate
2.4.4 Threat of Substitutes: High
2.4.5 Competitive Rivalry: High
2.5 PEST Analysis
2.6 Sustainability and ESG Trends
2.6.1 Sustainability Trends
2.6.2 Environmental Trends
2.6.3 Social Trends
2.6.4 Governance Trends
2.7 Regulatory Framework
2.8 Market Entry Barriers
2.8.1 Regulatory Aspect
2.8.2 Competitive Aspect
2.8.3 Reimbursement-Related Aspect
2.9 CMS Vs Colistin Base Sulphate – Manufacturing & Commercial Assessment
2.10 Global Tender Analysis
2.11 Prevalence of Key 3 Diseases, By Region, 2024
2.12 Pricing Analysis, ASPs of Key Products
2.13 Global Colistin API Market Volume (Tonnes), 2025
2.14 Pipeline Analysis of Next-Generation Polymyxins
3. COMPETITIVE LANDSCAPE
3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis (%), 2025
3.3 Market Concentration
4. COLISTIN MARKET – KEY INDUSTRY DYNAMICS
4.1 Market Drivers
4.1.1 Increased Multidrug-Resistant Gram-Negative Infections in Human Healthcare:
4.1.2 Sustained Veterinary Demand in Livestock and Poultry Farming
4.1.3 Regulatory Shifts and Policies Addressing Antimicrobial Resistance
4.2 Market Restraints
4.2.1 Limiting Clinical Adoption
4.2.2 Increased Prevalence of Colistin Resistance
4.2.3 Stringent Regulatory Policies and Bans
4.3 Market Opportunities
4.3.1 Advancements in Inhaled Colistin Formulations for Respiratory Infections
4.3.2 Expansion of Combination Therapies for Multidrug-Resistant Infections
4.3.3 Regional Market Expansion in Asia Pacific Amid Rising Antimicrobial Resistance
4.4 Future Trends
4.4.1 Advancements in Novel Formulations and Delivery Systems
4.4.2 Rise in Combination and Synergistic Therapies
4.4.3 Enhanced Antimicrobial Stewardship and Regulatory Frameworks
4.5 Impact of Drivers and Restraints
5. COLISTIN MARKET – GLOBAL MARKET ANALYSIS
5.1 Colistin Market Revenue (US$ Million), 2021–2034
5.2 Colistin Market Forecast and Analysis
6. COLISTIN MARKET REVENUE ANALYSIS – FORMULATION
6.1 Colistin Market Forecasts and Analysis by Formulation
6.1.1 Oral
6.1.1.1 Overview
6.1.1.2 Oral: Colistin Market – Revenue, 2021–2034 (US$ Million)
6.1.2 Injectables (IV or IM)
6.1.2.1 Overview
6.1.2.2 Injectables (IV or IM): Colistin Market – Revenue, 2021–2034 (US$ Million)
6.1.3 Topical Formulations
6.1.3.1 Overview
6.1.3.2 Topical Formulations: Colistin Market – Revenue, 2021–2034 (US$ Million)
6.1.4 Inhalation Solutions
6.1.4.1 Overview
6.1.4.2 Inhalation Solutions: Colistin Market – Revenue, 2021–2034 (US$ Million)
7. COLISTIN MARKET REVENUE ANALYSIS – INDICATION
7.1 Colistin Market Forecasts and Analysis by Indication
7.1.1 Animal Health
7.1.1.1 Overview
7.1.1.2 Animal Health Health: Colistin Market – Revenue, 2021–2034 (US$ Million)
7.1.2 Human Health
7.1.2.1 Overview
7.1.2.2 Human Health: Colistin Market – Revenue, 2021–2034 (US$ Million)
8. COLISTIN MARKET REVENUE ANALYSIS – DISTRIBUTION CHANNEL
8.1 Colistin Market Forecasts and Analysis by Distribution Channel
8.1.1 Hospital Pharmacy
8.1.1.1 Overview
8.1.1.2 Hospital Pharmacy: Colistin Market – Revenue, 2021–2034 (US$ Million)
8.1.2 Retail Pharmacy
8.1.2.1 Overview
8.1.2.2 Retail Pharmacy: Colistin Market – Revenue, 2021–2034 (US$ Million)
8.1.3 Online Channel
8.1.3.1 Overview
8.1.3.2 Online Channel: Colistin Market – Revenue, 2021–2034 (US$ Million)
8.1.4 Other Distribution Channel
8.1.4.1 Overview
8.1.4.2 Other Distribution Channel: Colistin Market – Revenue, 2021–2034 (US$ Million)
9. COLISTIN MARKET – GEOGRAPHICAL ANALYSIS
9.1 North America
9.1.1 North America Colistin Market Overview
9.1.2 North America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.3 North America: Colistin Market – By Segmentation
9.1.3.1 Formulation
9.1.3.2 Indication
9.1.3.2.1 Human Health
9.1.3.3 Distribution Channel
9.1.4 North America: Colistin Market Breakdown by Countries
9.1.4.1 United States Market
9.1.4.1.1 United States: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.4.1.2 United States: Colistin Market – By Segmentation
9.1.4.1.2.1 Formulation
9.1.4.1.2.2 Indication
9.1.4.1.2.2.1 Human Health
9.1.4.1.2.3 Distribution Channel
9.1.4.2 Canada Market
9.1.4.2.1 Canada: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.4.2.2 Canada: Colistin Market – By Segmentation
9.1.4.2.2.1 Formulation
9.1.4.2.2.2 Indication
9.1.4.2.2.2.1 Human Health
9.1.4.2.2.3 Distribution Channel
9.1.4.3 Mexico Market
9.1.4.3.1 Mexico: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.1.4.3.2 Mexico: Colistin Market – By Segmentation
9.1.4.3.2.1 Formulation
9.1.4.3.2.2 Indication
9.1.4.3.2.2.1 Human Health
9.1.4.3.2.3 Distribution Channel
9.2 Europe
9.2.1 Europe Colistin Market Overview
9.2.2 Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.3 Europe: Colistin Market – By Segmentation
9.2.3.1 Formulation
9.2.3.2 Indication
9.2.3.2.1 Human Health
9.2.3.3 Distribution Channel
9.2.4 Europe: Colistin Market Breakdown by Countries
9.2.4.1 Germany Market
9.2.4.1.1 Germany: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.1.2 Germany: Colistin Market – By Segmentation
9.2.4.1.2.1 Formulation
9.2.4.1.2.2 Indication
9.2.4.1.2.2.1 Human Health
9.2.4.1.2.3 Distribution Channel
9.2.4.2 United Kingdom Market
9.2.4.2.1 United Kingdom: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.2.2 United Kingdom: Colistin Market – By Segmentation
9.2.4.2.2.1 Formulation
9.2.4.2.2.2 Indication
9.2.4.2.2.2.1 Human Health
9.2.4.2.2.3 Distribution Channel
9.2.4.3 France Market
9.2.4.3.1 France: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.3.2 France: Colistin Market – By Segmentation
9.2.4.3.2.1 Formulation
9.2.4.3.2.2 Indication
9.2.4.3.2.2.1 Human Health
9.2.4.3.2.3 Distribution Channel
9.2.4.4 Italy Market
9.2.4.4.1 Italy: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.4.2 Italy: Colistin Market – By Segmentation
9.2.4.4.2.1 Formulation
9.2.4.4.2.2 Indication
9.2.4.4.2.2.1 Human Health
9.2.4.4.2.3 Distribution Channel
9.2.4.5 Spain Market
9.2.4.5.1 Spain: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.5.2 Spain: Colistin Market – By Segmentation
9.2.4.5.2.1 Formulation
9.2.4.5.2.2 Indication
9.2.4.5.2.2.1 Human Health
9.2.4.5.2.3 Distribution Channel
9.2.4.6 Poland Market
9.2.4.6.1 Poland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.6.2 Poland: Colistin Market – By Segmentation
9.2.4.6.2.1 Formulation
9.2.4.6.2.2 Indication
9.2.4.6.2.2.1 Human Health
9.2.4.6.2.3 Distribution Channel
9.2.4.7 Romania Market
9.2.4.7.1 Romania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.7.2 Romania: Colistin Market – By Segmentation
9.2.4.7.2.1 Formulation
9.2.4.7.2.2 Indication
9.2.4.7.2.2.1 Human Health
9.2.4.7.2.3 Distribution Channel
9.2.4.8 Serbia Market
9.2.4.8.1 Serbia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.8.2 Serbia: Colistin Market – By Segmentation
9.2.4.8.2.1 Formulation
9.2.4.8.2.2 Indication
9.2.4.8.2.2.1 Human Health
9.2.4.8.2.3 Distribution Channel
9.2.4.9 Bulgaria Market
9.2.4.9.1 Bulgaria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.9.2 Bulgaria: Colistin Market – By Segmentation
9.2.4.9.2.1 Formulation
9.2.4.9.2.2 Indication
9.2.4.9.2.2.1 Human Health
9.2.4.9.2.3 Distribution Channel
9.2.4.10 Czech Republic Market
9.2.4.10.1 Czech Republic: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.10.2 Czech Republic: Colistin Market – By Segmentation
9.2.4.10.2.1 Formulation
9.2.4.10.2.2 Indication
9.2.4.10.2.2.1 Human Health
9.2.4.10.2.3 Distribution Channel
9.2.4.11 Belgium Market
9.2.4.11.1 Belgium: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.11.2 Belgium: Colistin Market – By Segmentation
9.2.4.11.2.1 Formulation
9.2.4.11.2.2 Indication
9.2.4.11.2.2.1.1 Human Health
9.2.4.11.2.3 Distribution Channel
9.2.4.12 Slovakia Market
9.2.4.12.1 Slovakia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.12.2 Slovakia: Colistin Market – By Segmentation
9.2.4.12.2.1 Formulation
9.2.4.12.2.2 Indication
9.2.4.12.2.2.1 Human Health
9.2.4.12.2.3 Distribution Channel
9.2.4.13 Ireland Market
9.2.4.13.1 Ireland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.13.2 Ireland: Colistin Market – By Segmentation
9.2.4.13.2.1 Formulation
9.2.4.13.2.2 Indication
9.2.4.13.2.2.1 Human Health
9.2.4.13.2.3 Distribution Channel
9.2.4.14 Hungary Market
9.2.4.14.1 Hungary: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.14.2 Hungary: Colistin Market – By Segmentation
9.2.4.14.2.1 Formulation
9.2.4.14.2.2 Indication
9.2.4.14.2.2.1 Human Health
9.2.4.14.2.3 Distribution Channel
9.2.4.15 Portugal Market
9.2.4.15.1 Portugal: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.15.2 Portugal: Colistin Market – By Segmentation
9.2.4.15.2.1 Formulation
9.2.4.15.2.2 Indication
9.2.4.15.2.2.1 Human Health
9.2.4.15.2.3 Distribution Channel
9.2.4.16 Lithuania Market
9.2.4.16.1 Lithuania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.16.2 Lithuania: Colistin Market – By Segmentation
9.2.4.16.2.1 Formulation
9.2.4.16.2.2 Indication
9.2.4.16.2.2.1 Human Health
9.2.4.16.2.3 Distribution Channel
9.2.4.17 Austria Market
9.2.4.17.1 Austria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.17.2 Austria: Colistin Market – By Segmentation
9.2.4.17.2.1 Formulation
9.2.4.17.2.2 Indication
9.2.4.17.2.2.1 Human Health
9.2.4.17.2.3 Distribution Channel
9.2.4.18 Bosnia Market
9.2.4.18.1 Bosnia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.18.2 Bosnia: Colistin Market – By Segmentation
9.2.4.18.2.1 Formulation
9.2.4.18.2.2 Indication
9.2.4.18.2.2.1 Human Health
9.2.4.18.2.3 Distribution Channel
9.2.4.19 Latvia Market
9.2.4.19.1 Latvia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.19.2 Latvia: Colistin Market – By Segmentation
9.2.4.19.2.1 Formulation
9.2.4.19.2.2 Indication
9.2.4.19.2.2.1 Human Health
9.2.4.19.2.3 Distribution Channel
9.2.4.20 Netherlands Market
9.2.4.20.1 Netherlands: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.20.2 Netherlands: Colistin Market – By Segmentation
9.2.4.20.2.1 Formulation
9.2.4.20.2.2 Indication
9.2.4.20.2.2.1 Human Health
9.2.4.20.2.3 Distribution Channel
9.2.4.21 Greece Market
9.2.4.21.1 Greece: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.21.2 Greece: Colistin Market – By Segmentation
9.2.4.21.2.1 Formulation
9.2.4.21.2.2 Indication
9.2.4.21.2.2.1 Human Health
9.2.4.21.2.3 Distribution Channel
9.2.4.22 Rest of Europe Market
9.2.4.22.1 Rest of Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.2.4.22.2 Rest of Europe: Colistin Market – By Segmentation
9.2.4.22.2.1 Formulation
9.2.4.22.2.2 Indication
9.2.4.22.2.2.1 Human Health
9.2.4.22.2.3 Distribution Channel
9.3 Asia Pacific
9.3.1 Asia Pacific Colistin Market Overview
9.3.2 Asia Pacific: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.3 Asia Pacific: Colistin Market – By Segmentation
9.3.3.1 Formulation
9.3.3.2 Indication
9.3.3.2.1 Human Health
9.3.3.3 Distribution Channel
9.3.4 Asia Pacific: Colistin Market Breakdown by Countries
9.3.4.1 Australia and New Zealand Market
9.3.4.1.1 Australia and New Zealand: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.1.2 Australia and New Zealand: Colistin Market – By Segmentation
9.3.4.1.2.1 Formulation
9.3.4.1.2.2 Indication
9.3.4.1.2.2.1 Human Health
9.3.4.1.2.3 Distribution Channel
9.3.4.2 Japan Market
9.3.4.2.1 Japan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.2.2 Japan: Colistin Market – By Segmentation
9.3.4.2.2.1 Formulation
9.3.4.2.2.2 Indication
9.3.4.2.2.2.1 Human Health
9.3.4.2.2.3 Distribution Channel
9.3.4.3 Kazakhstan Market
9.3.4.3.1 Kazakhstan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.3.2 Kazakhstan: Colistin Market – By Segmentation
9.3.4.3.2.1 Formulation
9.3.4.3.2.2 Indication
9.3.4.3.2.2.1 Human Health
9.3.4.3.2.3 Distribution Channel
9.3.4.4 Rest of APAC Market
9.3.4.4.1 Rest of APAC: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.3.4.4.2 Rest of APAC: Colistin Market – By Segmentation
9.3.4.4.2.1 Formulation
9.3.4.4.2.2 Indication
9.3.4.4.2.2.1 Human Health
9.3.4.4.2.3 Distribution Channel
9.4 Middle East and Africa
9.4.1 Middle East and Africa Colistin Market Overview
9.4.2 Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.4.3 Middle East and Africa: Colistin Market – By Segmentation
9.4.3.1 Formulation
9.4.3.2 Indication
9.4.3.2.1 Human Health
9.4.3.3 Distribution Channel
9.4.4 Middle East and Africa: Colistin Market Breakdown by Countries
9.4.4.1 Saudi Arabia Market
9.4.4.1.1 Saudi Arabia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.4.4.1.2 Saudi Arabia: Colistin Market – By Segmentation
9.4.4.1.2.1 Formulation
9.4.4.1.2.2 Indication
9.4.4.1.2.2.1 Human Health
9.4.4.1.2.3 Distribution Channel
9.4.4.2 Rest of Middle East and Africa Market
9.4.4.2.1 Rest of Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.4.4.2.2 Rest of Middle East and Africa: Colistin Market – By Segmentation
9.4.4.2.2.1 Formulation
9.4.4.2.2.2 Indication
9.4.4.2.2.2.1 Human Health
9.4.4.2.2.3 Distribution Channel
9.5 South and Central America
9.5.1 South and Central America Colistin Market Overview
9.5.2 South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.5.3 South and Central America: Colistin Market – By Segmentation
9.5.3.1 Formulation
9.5.3.2 Indication
9.5.3.2.1 Human Health
9.5.3.3 Distribution Channel
9.5.4 South and Central America: Colistin Market Breakdown by Countries
9.5.4.1 Brazil Market
9.5.4.1.1 Brazil: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.5.4.1.2 Brazil: Colistin Market – By Segmentation
9.5.4.1.2.1 Formulation
9.5.4.1.2.2 Indication
9.5.4.1.2.2.1 Human Health
9.5.4.1.2.3 Distribution Channel
9.5.4.2 Rest of South and Central America Market
9.5.4.2.1 Rest of South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
9.5.4.2.2 Rest of South and Central America: Colistin Market – By Segmentation
9.5.4.2.2.1 Formulation
9.5.4.2.2.2 Indication
9.5.4.2.2.2.1 Human Health
9.5.4.2.2.3 Distribution Channel
10. COLISTIN MARKET INDUSTRY LANDSCAPE
11. COLISTIN MARKET – KEY COMPANY PROFILES
11.1 Hebei Shengxue Dacheng Pharmaceutical Co., Ltd
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Norma Hellas S.A
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Apeloa Pharmaceutical Co., Ltd.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Livzon Pharmaceutical Group Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Shandong LuKang Pharmaceutical Co., Ltd
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Xellia Pharmaceuticals ApS
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Zhejiang Shenghua Biok Chemical Company Limited
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Fujian lifecome biochemistry Limited
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Tecoland Corporation
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 TZF Polfa S.A.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. APPENDIX
12.1 Glossary
12.2 Research Methodology and Approach
12.2.1 Secondary Research
12.2.2 Primary Research
12.2.3 Market Estimation Approach
12.2.3.1 Supply Side Analysis
12.2.3.2 Demand Side Analysis
12.2.4 Research Assumptions and Limitations
12.2.5 Currency Conversion
12.3 About The Insight Partners
12.4 Market Intelligence Cloud
LIST OF TABLES
Table 1. List of Regulatory Bodies and Organizations
Table 2. Ease of Doing Business: Key Country Rankings
Table 3. Market Entry Barriers
Table 4. CMS Vs Colistin Base Sulphate – Manufacturing & Commercial Assessment
Table 5. Global Tender Analysis
Table 6. Prevalence of Key 3 Diseases, By Region, 2024
Table 7. Pricing Analysis, ASPs of Key Products
Table 8. Global Colistin API Market Volume (Tonnes), 2025
Table 9. Global Colistin API Market Volume (Tonnes), 2025
Table 10. Pipeline Analysis of Next-Generation Polymyxins
Table 11. Market Share Analysis (%), 2025
Table 12. Colistin Market – Revenue, 2021–2025 (US$ Million)
Table 13. Colistin Market – Revenue Forecast, 2026–2034 (US$ Million)
Table 14. Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 15. Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 16. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 17. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 18. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 19. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 20. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 21. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 22. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 23. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 24. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 25. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 26. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 27. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 28. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 29. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 30. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 31. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 32. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 33. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 34. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 35. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 36. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 37. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 38. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 39. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 40. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 41. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 42. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 43. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 44. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 45. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 46. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 47. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 48. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 49. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 50. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 51. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 52. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 53. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 54. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 55. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 56. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 57. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 58. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 59. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 60. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 61. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 62. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 63. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 64. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 65. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 66. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 67. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 68. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 69. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 70. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 71. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 72. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 73. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 74. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 75. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 76. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 77. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 78. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 79. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 80. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 81. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 82. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 83. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 84. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 85. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 86. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 87. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 88. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 89. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 90. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 91. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 92. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 93. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 94. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 95. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 96. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 97. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 98. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 99. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 100. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 101. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 102. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 103. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 104. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 105. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 106. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 107. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 108. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 109. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 110. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 111. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 112. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 113. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 114. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 115. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 116. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 117. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 118. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 119. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 120. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 121. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 122. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 123. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 124. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 125. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 126. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 127. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 128. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 129. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 130. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 131. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 132. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 133. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 134. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 135. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 136. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 137. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 138. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 139. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 140. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 141. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 142. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 143. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 144. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 145. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 146. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 147. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 148. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 149. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 150. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 151. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 152. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 153. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 154. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 155. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 156. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 157. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 158. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 159. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 160. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 161. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 162. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 163. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 164. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 165. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 166. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 167. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 168. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 169. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 170. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 171. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 172. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 173. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 174. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 175. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 176. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 177. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 178. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 179. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 180. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 181. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 182. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 183. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 184. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 185. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 186. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 187. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 188. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 189. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 190. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 191. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 192. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 193. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 194. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 195. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 196. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 197. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 198. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 199. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 200. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 201. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 202. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 203. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 204. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 205. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 206. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 207. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 208. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 209. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 210. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 211. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 212. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 213. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 214. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 215. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 216. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 217. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 218. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 219. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 220. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 221. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 222. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 223. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 224. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 225. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 226. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 227. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 228. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 229. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 230. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 231. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 232. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 233. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 234. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 235. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 236. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 237. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 238. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 239. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 240. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 241. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 242. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 243. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 244. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 245. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 246. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 247. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 248. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 249. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 250. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 251. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 252. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 253. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 254. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 255. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 256. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 257. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 258. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 259. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 260. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 261. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 262. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 263. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 264. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 265. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 266. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 267. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 268. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 269. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 270. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 271. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 272. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 273. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 274. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 275. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 276. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 277. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 278. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 279. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 280. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 281. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 282. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 283. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 284. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 285. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 286. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 287. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 288. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 289. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 290. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 291. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 292. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 293. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 294. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 295. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 296. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 297. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 298. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 299. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 300. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 301. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 302. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 303. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 304. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 305. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 306. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 307. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 308. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 309. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 310. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 311. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 312. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 313. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 314. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 315. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 316. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 317. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 318. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 319. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 320. Glossary – Colistin Market
Table 1. List of Regulatory Bodies and Organizations
Table 2. Ease of Doing Business: Key Country Rankings
Table 3. Market Entry Barriers
Table 4. CMS Vs Colistin Base Sulphate – Manufacturing & Commercial Assessment
Table 5. Global Tender Analysis
Table 6. Prevalence of Key 3 Diseases, By Region, 2024
Table 7. Pricing Analysis, ASPs of Key Products
Table 8. Global Colistin API Market Volume (Tonnes), 2025
Table 9. Global Colistin API Market Volume (Tonnes), 2025
Table 10. Pipeline Analysis of Next-Generation Polymyxins
Table 11. Market Share Analysis (%), 2025
Table 12. Colistin Market – Revenue, 2021–2025 (US$ Million)
Table 13. Colistin Market – Revenue Forecast, 2026–2034 (US$ Million)
Table 14. Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 15. Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 16. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 17. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 18. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 19. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 20. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 21. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 22. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 23. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 24. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 25. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 26. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 27. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 28. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 29. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 30. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 31. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 32. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 33. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 34. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 35. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 36. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 37. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 38. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 39. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 40. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 41. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 42. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 43. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 44. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 45. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 46. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 47. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 48. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 49. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 50. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 51. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 52. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 53. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 54. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 55. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 56. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 57. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 58. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 59. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 60. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 61. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 62. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 63. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 64. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 65. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 66. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 67. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 68. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 69. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 70. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 71. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 72. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 73. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 74. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 75. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 76. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 77. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 78. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 79. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 80. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 81. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 82. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 83. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 84. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 85. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 86. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 87. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 88. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 89. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 90. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 91. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 92. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 93. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 94. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 95. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 96. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 97. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 98. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 99. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 100. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 101. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 102. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 103. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 104. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 105. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 106. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 107. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 108. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 109. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 110. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 111. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 112. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 113. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 114. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 115. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 116. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 117. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 118. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 119. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 120. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 121. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 122. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 123. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 124. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 125. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 126. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 127. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 128. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 129. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 130. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 131. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 132. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 133. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 134. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 135. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 136. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 137. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 138. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 139. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 140. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 141. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 142. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 143. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 144. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 145. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 146. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 147. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 148. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 149. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 150. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 151. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 152. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 153. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 154. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 155. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 156. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 157. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 158. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 159. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 160. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 161. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 162. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 163. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 164. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 165. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 166. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 167. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 168. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 169. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 170. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 171. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 172. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 173. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 174. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 175. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 176. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 177. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 178. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 179. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 180. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 181. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 182. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 183. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 184. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 185. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 186. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 187. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 188. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 189. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 190. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 191. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 192. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 193. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 194. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 195. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 196. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 197. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 198. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 199. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 200. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 201. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 202. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 203. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 204. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 205. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 206. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 207. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 208. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 209. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 210. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 211. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 212. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 213. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 214. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 215. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 216. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 217. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 218. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 219. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 220. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 221. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 222. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 223. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 224. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 225. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 226. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 227. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 228. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 229. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 230. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 231. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 232. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 233. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 234. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 235. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 236. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 237. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 238. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 239. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 240. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 241. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 242. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 243. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 244. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 245. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 246. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 247. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 248. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 249. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 250. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 251. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 252. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 253. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 254. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 255. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 256. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 257. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 258. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 259. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 260. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 261. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 262. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 263. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 264. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 265. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 266. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 267. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 268. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 269. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 270. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 271. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 272. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 273. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 274. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 275. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 276. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 277. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 278. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 279. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 280. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 281. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 282. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 283. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 284. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 285. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 286. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 287. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 288. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 289. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 290. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 291. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 292. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 293. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 294. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 295. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 296. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 297. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 298. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 299. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 300. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 301. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 302. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 303. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 304. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 305. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 306. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 307. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 308. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 309. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 310. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 311. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 312. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation
Table 313. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation
Table 314. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication
Table 315. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication
Table 316. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health
Table 317. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health
Table 318. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel
Table 319. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel
Table 320. Glossary – Colistin Market
LIST OF FIGURES
Figure 1. Colistin Market Segmentation.
Figure 2. Colistin Market – Value Chain Analysis
Figure 3. Porter’s Five Forces Analysis
Figure 4. Pest Analysis
Figure 5. Colistin Market – Key Industry Dynamics
Figure 6. Impact Analysis of Drivers and Restraints
Figure 7. Colistin Market Revenue (US$ Million), 2021–2034
Figure 8. Colistin Market Share (%) – by Formulation (2025 and 2034)
Figure 9. Oral: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 10. Injectables (IV or IM): Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 11. Topical Formulations: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 12. Inhalation Solutions: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 13. Colistin Market Share (%) – by Indication (2025 and 2034)
Figure 14. Human Health: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 15. Human Health: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 16. Colistin Market Share (%) – by Distribution Channel (2025 and 2034)
Figure 17. Hospital Pharmacy: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 18. Retail Pharmacy: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 19. Online Channel: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 20. Other Distribution Channel: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 21. North America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 22. North America: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 23. United States: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 24. Canada: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 25. Mexico: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 26. Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 27. Europe: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 28. Germany: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 29. United Kingdom: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 30. France: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 31. Italy: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 32. Spain: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 33. Poland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 34. Romania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 35. Serbia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 36. Bulgaria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 37. Czech Republic: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 38. Belgium: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 39. Slovakia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 40. Ireland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 41. Hungary: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 42. Portugal: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 43. Lithuania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 44. Austria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 45. Bosnia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 46. Latvia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 47. Netherlands: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 48. Greece: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 49. Rest of Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 50. Asia Pacific: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 51. Asia Pacific: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 52. Australia and New Zealand: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 53. Japan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 54. Kazakhstan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 55. Rest of APAC: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 56. Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 57. Middle East and Africa: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 58. Saudi Arabia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 59. Rest of Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 60. South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 61. South and Central America: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 62. Brazil: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 63. Rest of South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 64. Bottom–Up Approach and Top–Down Approach
Figure 1. Colistin Market Segmentation.
Figure 2. Colistin Market – Value Chain Analysis
Figure 3. Porter’s Five Forces Analysis
Figure 4. Pest Analysis
Figure 5. Colistin Market – Key Industry Dynamics
Figure 6. Impact Analysis of Drivers and Restraints
Figure 7. Colistin Market Revenue (US$ Million), 2021–2034
Figure 8. Colistin Market Share (%) – by Formulation (2025 and 2034)
Figure 9. Oral: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 10. Injectables (IV or IM): Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 11. Topical Formulations: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 12. Inhalation Solutions: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 13. Colistin Market Share (%) – by Indication (2025 and 2034)
Figure 14. Human Health: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 15. Human Health: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 16. Colistin Market Share (%) – by Distribution Channel (2025 and 2034)
Figure 17. Hospital Pharmacy: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 18. Retail Pharmacy: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 19. Online Channel: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 20. Other Distribution Channel: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 21. North America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 22. North America: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 23. United States: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 24. Canada: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 25. Mexico: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 26. Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 27. Europe: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 28. Germany: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 29. United Kingdom: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 30. France: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 31. Italy: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 32. Spain: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 33. Poland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 34. Romania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 35. Serbia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 36. Bulgaria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 37. Czech Republic: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 38. Belgium: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 39. Slovakia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 40. Ireland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 41. Hungary: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 42. Portugal: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 43. Lithuania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 44. Austria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 45. Bosnia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 46. Latvia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 47. Netherlands: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 48. Greece: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 49. Rest of Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 50. Asia Pacific: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 51. Asia Pacific: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 52. Australia and New Zealand: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 53. Japan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 54. Kazakhstan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 55. Rest of APAC: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 56. Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 57. Middle East and Africa: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 58. Saudi Arabia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 59. Rest of Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 60. South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 61. South and Central America: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 62. Brazil: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 63. Rest of South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)
Figure 64. Bottom–Up Approach and Top–Down Approach
